Keywords: virexx, completes, 12m, financing, canada, medical, company

ViRexx completes $12M financing

Article | 20 February 2006

Canada's ViRexx Medical, a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B and C and embolotherapy treatments ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing